GlassScriptPhysician profile
Matthew J Dzurik
NPI 1285895169
$142,292.57
in general payments reported to CMS, 2019-2025
20 companies · $24K in 2025
The $24K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $6,470 · 2021: $14K · 2022: $38K · 2023: $18K · 2024: $18K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $46K · Consulting Fee: $7,875 · Acquisitions: $2,323 · Travel and Lodging: $1,706 · Food and Beverage: $1,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $45,977.81 |
| Consulting Fee | $7,875.00 |
| Acquisitions | $2,322.69 |
| Travel and Lodging | $1,705.66 |
| Food and Beverage | $1,366.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $86,151.22 | 2019-2025 | Biobrace 23mm, Hercules Suture Anchor System, Neospan |
| In2bones USA, LLC | $52,734.07 | 2019-2022 | |
| Intelivation Technologies, LLC | $2,250.00 | 2021-2023 | |
| Organogenesis INC. | $281.70 | 2019-2024 | Puraply, Puraply Franchise |
| Horizon Therapeutics Plc | $244.66 | 2019-2022 | |
| Smith+Nephew, INC. | $162.35 | 2020-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| Amgen INC. | $92.13 | 2024-2025 | Krystexxa |
| Forma Medical | $69.76 | 2024 | Optimalakin |
| Convatec INC. | $54.70 | 2024-2025 | |
| Nevro Corp. | $34.59 | 2022 | |
| Orthofix Medical, INC. | $33.58 | 2023 | Physio-Stim, Cervical-Stim |
| Ossio INC | $28.36 | 2023 | |
| Abbvie INC. | $27.86 | 2025 | |
| Abbott Laboratories | $24.86 | 2024 | Eterna |
| Wright Medical Technology, INC. | $23.26 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $19.43 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.96 | 2021 | |
| Paragon 28, INC. | $15.68 | 2019 | |
| Kci USA, INC. | $15.40 | 2019 | |
| Zyla Life Sciences, INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Dzurik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.